The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation.

Gaurav Kumar Pandey,Sanhita Mitra,Santhilal Subhash,Falk Hertwig,Meena Kanduri,Kankadeb Mishra,Susanne Fransson,Abiarchana Ganeshram,Tanmoy Mondal,Sashidhar Bandaru,Malin Ostensson,Levent M Akyürek,Jonas Abrahamsson,Susan Pfeifer,Erik Larsson,Leming Shi,Zhiyu Peng,Matthias Fischer,Tommy Martinsson,Fredrik Hedborg,Per Kogner,Chandrasekhar Kanduri
DOI: https://doi.org/10.1016/j.ccell.2014.09.014
IF: 50.3
2014-01-01
Cancer Cell
Abstract:Neuroblastoma is an embryonal tumor of the sympathetic nervous system and the most common extracranial tumor of childhood. By sequencing transcriptomes of low- and high-risk neuroblastomas, we detected differentially expressed annotated and nonannotated long noncoding RNAs (lncRNAs). We identified a lncRNA neuroblastoma associated transcript-1 (NBAT-1) as a biomarker significantly predicting clinical outcome of neuroblastoma. CpG methylation and a high-risk neuroblastoma associated SNP on chromosome 6p22 functionally contribute to NBAT-1 differential expression. Loss of NBAT-1 increases cellular proliferation and invasion. It controls these processes via epigenetic silencing of target genes. NBAT-1 loss affects neuronal differentiation through activation of the neuronal-specific transcription factor NRSF/REST. Thus, loss of NBAT-1 contributes to aggressive neuroblastoma by increasing proliferation and impairing differentiation of neuronal precursors.
What problem does this paper attempt to address?